These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


404 related items for PubMed ID: 12942122

  • 21. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women.
    Manavi M, Hudelist G, Fink-Retter A, Gschwantler-Kaulich D, Pischinger K, Czerwenka K.
    Int J Gynecol Cancer; 2008; 18(2):285-94. PubMed ID: 17587315
    [Abstract] [Full Text] [Related]

  • 22. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
    van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, Verheijen RH, Helmerhorst TJ, Meijer CJ, Walboomers JM.
    J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
    Pista A, de Oliveira CF, Lopes C, Cunha MJ, CLEOPATRE Portugal Study Groupa.
    Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.
    Kang WD, Kim CH, Cho MK, Kim JW, Kim YH, Choi HS, Kim SM.
    Int J Gynecol Cancer; 2009 Jul; 19(5):924-8. PubMed ID: 19574786
    [Abstract] [Full Text] [Related]

  • 26. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
    Li Y, Ye F, Lü WG, Zeng WJ, Wei LH, Xie X.
    Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
    [Abstract] [Full Text] [Related]

  • 27. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
    Bonds L, Baker P, Gup C, Shroyer KR.
    Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia.
    Menczer J, Fintsi Y, Arbel-Alon S, Tell L, Friedman E, Jackman A, Sherman L.
    Eur J Gynaecol Oncol; 2000 Oct; 21(1):30-4. PubMed ID: 10726615
    [Abstract] [Full Text] [Related]

  • 33. Expression of p16INK4A in cervical precancerous lesions that is unlikely to be preventable by human papillomavirus vaccines.
    Badiga S, Chambers MM, Huh W, Eltoum IA, Piyathilake CJ.
    Cancer; 2016 Dec 01; 122(23):3615-3623. PubMed ID: 27479745
    [Abstract] [Full Text] [Related]

  • 34. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan 01; 41(1):34-7. PubMed ID: 16635326
    [Abstract] [Full Text] [Related]

  • 35. Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions.
    Skyldberg B, Fujioka K, Hellström AC, Sylvén L, Moberger B, Auer G.
    Mod Pathol; 2001 Apr 01; 14(4):279-84. PubMed ID: 11301343
    [Abstract] [Full Text] [Related]

  • 36. Association between HPV types and species groups and cervical neoplasia from a high-risk area for cervical cancer, Goiânia, Brazil.
    Ribeiro AA, Figueiredo Alves RR, Costa MC, Villa LL, Zeferino LC, Mauricette Derchain SF, Dos Santos Carneiro MA, Rabelo-Santos SH.
    Int J Gynecol Pathol; 2011 May 01; 30(3):288-94. PubMed ID: 21464724
    [Abstract] [Full Text] [Related]

  • 37. Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: presumed precursors of adenocarcinoma of the uterine cervix.
    Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS, Faras AJ.
    Obstet Gynecol; 1989 Jun 01; 73(6):1005-8. PubMed ID: 2542853
    [Abstract] [Full Text] [Related]

  • 38. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
    Limpaiboon T, Pooart J, Bhattarakosol P, Niruthisard S, Chantratita W, Lulitanond V.
    Southeast Asian J Trop Med Public Health; 2000 Mar 01; 31(1):66-71. PubMed ID: 11023067
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of human papillomavirus DNA in cervical tissue. Retrospective analysis of 855 cervical biopsies.
    Backe J, Roos T, Mulfinger L, Martius J.
    Arch Gynecol Obstet; 1997 Mar 01; 259(2):69-77. PubMed ID: 9059747
    [Abstract] [Full Text] [Related]

  • 40. Comparative Study on Detection and Typing of Human Papillomavirus (HPV) Infection with Microarray Using Paraffin-Embedded Specimens from Squamous Cell Carcinoma and Cervical Precursor Lesions.
    Gong P, Wang Z, Geng J, Tan X.
    J Nanosci Nanotechnol; 2017 Feb 01; 17(2):990-97. PubMed ID: 29671971
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.